A detailed history of May Hill Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, May Hill Capital, LLC holds 4,525 shares of AZN stock, worth $336,795. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,525
Holding current value
$336,795
% of portfolio
0.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$63.2 - $79.58 $285,980 - $360,099
4,525 New
4,525 $296 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $231B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track May Hill Capital, LLC Portfolio

Follow May Hill Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of May Hill Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on May Hill Capital, LLC with notifications on news.